FOXO1 and type 2 diabetes mellitus: As a major treatment for T2DM, metformin has been found to activate Sirt1/FoxO1 autophagic signaling so as to reduce renal damage, thereby indicating that modulation of autophagy pathways may help to prevent and/or delay DKD (116).